Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldblatt

Showing results (141-150 of 242) with videos related to

Pageof 25
Sort By:
The Pediatric Infectious Disease Journal|October 24, 2002
Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccineStephen K Obaro, Godwin C Enwere, Maria Deloria, et al.
Vaccine|May 20, 2018
Development of an opsonophagocytic killing assay for group a streptococcusScott Jones, Nicole J Moreland, Marta Zancolli, et al.
The Journal of Infectious Diseases|July 5, 2005
Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household studyDavid Goldblatt, Mahein Hussain, Nick Andrews, et al.
Biologicals : Journal of the International Association of Biological Standardization|November 17, 2023
Enabling the evaluation of COVID-19 vaccines with correlates of protectionArnaud Marchant, Pierre Van Damme, Stanley Plotkin, et al.
The Pediatric Infectious Disease Journal|December 8, 2022
A Randomized Trial Assessing the Immunogenicity and Reactogenicity of Two Hexavalent Infant Vaccines Concomitantly Administered With Group B Meningococcal VaccineMatthew Rajan, Natalie Marchevsky, Gemma Sinclair, et al.
Vaccine|February 16, 2011
The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization scheduleMartin O Ota, Adebayo Akinsola, John Townend, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2020
Preclinical Development of Virulence-attenuated <i>Streptococcus pneumoniae</i> Strains Able to Enhance Protective Immunity against Pneumococcal InfectionElisa Ramos-Sevillano, Giuseppe Ercoli, Philip Felgner, et al.
The Lancet. Global Health|February 9, 2016
Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance studyLaura L Hammitt, Rosie J Crane, Angela Karani, et al.
The Lancet. Infectious Diseases|November 28, 2017
Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trialDavid Goldblatt, Jo Southern, Nick J Andrews, et al.
The Journal of Infectious Diseases|June 23, 2021
Thirteen-Valent Pneumococcal Conjugate Vaccine-Induced Immunoglobulin G (IgG) Responses in Serum Associated With Serotype-Specific IgG in the LungElena Mitsi, Daniella McLenaghan, Asia-Sophia Wolf, et al.
Pageof 25

Showing results (141-150 of 242) with videos related to

Sort By:
Pageof 25
The Pediatric Infectious Disease Journal|October 24, 2002
Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccineStephen K Obaro, Godwin C Enwere, Maria Deloria, et al.
Vaccine|May 20, 2018
Development of an opsonophagocytic killing assay for group a streptococcusScott Jones, Nicole J Moreland, Marta Zancolli, et al.
The Journal of Infectious Diseases|July 5, 2005
Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household studyDavid Goldblatt, Mahein Hussain, Nick Andrews, et al.
Biologicals : Journal of the International Association of Biological Standardization|November 17, 2023
Enabling the evaluation of COVID-19 vaccines with correlates of protectionArnaud Marchant, Pierre Van Damme, Stanley Plotkin, et al.
The Pediatric Infectious Disease Journal|December 8, 2022
A Randomized Trial Assessing the Immunogenicity and Reactogenicity of Two Hexavalent Infant Vaccines Concomitantly Administered With Group B Meningococcal VaccineMatthew Rajan, Natalie Marchevsky, Gemma Sinclair, et al.
Vaccine|February 16, 2011
The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization scheduleMartin O Ota, Adebayo Akinsola, John Townend, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2020
Preclinical Development of Virulence-attenuated <i>Streptococcus pneumoniae</i> Strains Able to Enhance Protective Immunity against Pneumococcal InfectionElisa Ramos-Sevillano, Giuseppe Ercoli, Philip Felgner, et al.
The Lancet. Global Health|February 9, 2016
Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance studyLaura L Hammitt, Rosie J Crane, Angela Karani, et al.
The Lancet. Infectious Diseases|November 28, 2017
Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trialDavid Goldblatt, Jo Southern, Nick J Andrews, et al.
The Journal of Infectious Diseases|June 23, 2021
Thirteen-Valent Pneumococcal Conjugate Vaccine-Induced Immunoglobulin G (IgG) Responses in Serum Associated With Serotype-Specific IgG in the LungElena Mitsi, Daniella McLenaghan, Asia-Sophia Wolf, et al.
Pageof 25